Scrambler therapy for chemotherapy-induced peripheral neuropathy: A case report

Area of Science:

• Neurology
• Oncology
• Pain Management

Background:

• Chemotherapy-induced peripheral neuropathy (CIPN) is a prevalent, debilitating side effect of cancer treatment.
• Existing pharmacological treatments for CIPN often lack efficacy or are poorly tolerated.
• Scrambler Therapy (ST), a non-invasive neuromodulation technique, shows promise for neuropathic pain, but optimal protocols are unknown.

Purpose of the Study:

• To evaluate the effectiveness of Scrambler Therapy in alleviating pain and enhancing functional status in a patient with CIPN.
• To assess the impact of ST on symptom relief and daily functioning in a single-case study.

Main Methods:

• A single patient diagnosed with CIPN underwent a series of Scrambler Therapy sessions.
• Standardized assessment tools were employed to measure pain levels and functional status pre-therapy, during therapy, and post-therapy.

Main Results:

• The patient experienced significant reductions in pain intensity following ST treatment.
• Notable improvements in functional status were observed and sustained for several weeks to months post-therapy.
• These findings suggest potential long-term benefits of ST for managing CIPN symptoms.

Conclusions:

• Scrambler Therapy demonstrates potential as an effective, non-invasive treatment for reducing pain and improving function in CIPN patients.
• ST may offer a viable alternative to conventional treatments for managing neuropathic pain in oncology patients.
• Further research into optimal ST dosing regimens is warranted.